NEIL3 D132V does not cleave 5-guanidinohydantoin (Gh)

Stable Identifier
R-HSA-9629245
Type
Reaction [transition]
Species
Homo sapiens
Compartment
nucleoplasm
ReviewStatus
5/5
Locations in the PathwayBrowser
Expand all
General
SVG | 
PNG
Low
Medium
High
 | PPTX  | SBGN
NEIL3 D132V does not cleave 5-guanidinohydantoin (Gh)
Click the image above or here to open this reaction in the Pathway Browser
The layout of this reaction may differ from that in the pathway view due to the constraints in pathway layout
NEIL3 D132V is a NEIL3 disease variant caused by a missense mutation that results in the substitution of aspartic acid residue (D) at position 132 to valine (V). NEIL3 D132V is unable to cleave 5-guanidinohydantoin (Gh) from oxidatively damaged DNA. Individuals harbouring a homozygous NEIL3 D132V mutation are predisposed to development of autoimmune diseases (Massaad et al. 2016). Primary fibroblasts from a patient with a NEIL3 D132V homozygous mutation show an increase in telomere loss compared to control wild type fibroblasts derived from the patient's healthy sibling (Zhou et al. 2017).
Literature References
PubMed ID Title Journal Year
27760045 Deficiency of base excision repair enzyme NEIL3 drives increased predisposition to autoimmunity

Chou, J, Megarbane, A, Ohsumi, TK, Jabara, H, Geha, RS, Al-Herz, W, Aldhekri, H, Tsokos, GC, Glauzy, S, Morbach, H, Olson, BG, Manis, JP, Al-Idrissi, E, Schmitz, K, Kyriacos, M, Chouery, E, Torisu, K, Nakabeppu, Y, Massaad, MJ, Wallace, SS, Kane, J, Zhou, J, Mizui, M, Janssen, E, Kang, PB, Meffre, E, Notarangelo, LD, Tsuchimoto, D

J. Clin. Invest. 2016
Participants
Input
Participates
as an event of
Normal reaction
NEIL3 cleaves 5-guanidinohydantoin (Homo sapiens)
Functional status

Loss of function of NEIL3 D132V:Gh-DNA [nucleoplasm]

Normal Entity
Disease Entity
Status
Disease
Name Identifier Synonyms
autoimmune hypersensitivity disease DOID:417 autoimmune disease, hypersensitivity reaction type II disease
Authored
Orlic-Milacic, M  (2019-01-05)
Reviewed
Zhou, J  (2019-02-11)
Created
Orlic-Milacic, M  (2018-11-20)
Cite Us!